TP53 and cancer: Moreover, studies with genetically engineered mice have shown that restoring wt TRP53 function in cancers that were caused by its absence potently inhibits tumour expansion by inducing either apoptosis or cell cycle arrest/cellular senescence, dependent on the tumour type [7–9].